Bio-Rad Laboratories this week launched the ProteinChip SELDI Standardization Suite, which is “designed to ensure that ProteinChip SELDI systems provide consistent, reproducible results over time, operators, and locations,” the company said in a statement.
The suite includes the ProteinChip System Starter kit serving as a training tool; ProteinChip Data Manager Software 3.5; ProteinChip OQ kit for use in regulated laboratories to perform detector calibration and show system reader compliance to nine operational specifications for sensitivity, resolution, and mass accuracy; ProteinChip System Check kit for detector compliance and to show reader compliance to four operational specifications for sensitivity and resolution; ProteinChip Detector Calibration kit; ProteinChip Peptide Mass Calibration kit; and ProteinChip SELDI System Components Upgrade service.
Australian diagnostics firm HealthLinx and partner ARL Pathology this launched the OvPlex early stage ovarian cancer test. HealthLinx said it is the first test of its kind.
OvPlex detects the presence of five protein biomarkers linked to ovarian caner in patient blood samples. HealthLinx claims that its biomarker panel can detect cancer with greater accuracy than the CA125 biomarker.
The test is initially being made available through general practitioners in Melbourne and costs A$200.